aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60).

Cash, cash equivalents and investments as of September 30, 2021 were $116.4 million.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.